NDC 0169-4915 – Wegovy

Semaglutide 3.2 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0169-4915

Product details

Brand name
Wegovy
Generic name
Semaglutide
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA215256
Marketed since
June 5, 2021
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Wegovy →

Package NDC codes (0)

Package NDCDescriptionSince

Other Wegovy products